Shanghai Medicilon Inc (688202) - Total Liabilities

Latest as of March 2026: CN¥807.85 Million CNY ≈ $118.21 Million USD

Based on the latest financial reports, Shanghai Medicilon Inc (688202) has total liabilities worth CN¥807.85 Million CNY (≈ $118.21 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Shanghai Medicilon Inc - Total Liabilities Trend (2016–2025)

This chart illustrates how Shanghai Medicilon Inc's total liabilities have evolved over time, based on quarterly financial data. See Shanghai Medicilon Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Shanghai Medicilon Inc Competitors by Total Liabilities

The table below lists competitors of Shanghai Medicilon Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Procter & Gamble Health Limited NSE:PGHL	India	Rs2.75 Billion
SHANG.FOS.PHARM.GR.H YC 1 F:08HH	Germany	€59.30 Billion
Xinke Material SHG:600255	China	CN¥2.59 Billion
Shanghai Yaoji Playing Card Co Ltd SHE:002605	China	CN¥1.57 Billion
Hainan Development Holdings Nanhai Co Ltd SHE:002163	China	CN¥4.96 Billion
Voltamp Transformers Limited NSE:VOLTAMP	India	Rs2.26 Billion
Reysas Tasimacilik ve Lojistik Ticaret AS IS:RYSAS	Turkey	TL13.23 Billion
Yantai Changyu Pioneer Wine Co Ltd SHE:000869	China	CN¥1.45 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Shanghai Medicilon Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688202 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.41	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.29	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Medicilon Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Medicilon Inc (2016–2025)

The table below shows the annual total liabilities of Shanghai Medicilon Inc from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥687.85 Million ≈ $100.65 Million	+0.70%
2024-12-31	CN¥683.10 Million ≈ $99.96 Million	-9.53%
2023-12-31	CN¥755.07 Million ≈ $110.49 Million	+3.89%
2022-12-31	CN¥726.80 Million ≈ $106.35 Million	+55.94%
2021-12-31	CN¥466.06 Million ≈ $68.20 Million	+103.81%
2020-12-31	CN¥228.67 Million ≈ $33.46 Million	+79.02%
2019-12-31	CN¥127.73 Million ≈ $18.69 Million	+2.13%
2018-12-31	CN¥125.06 Million ≈ $18.30 Million	+22.27%
2017-12-31	CN¥102.29 Million ≈ $14.97 Million	+3.52%
2016-12-31	CN¥98.81 Million ≈ $14.46 Million	--

About Shanghai Medicilon Inc

SHG:688202 China Biotechnology

Market Cap

$1.12 Billion

CN¥7.66 Billion CNY

Market Cap Rank

#8570 Global

#2124 in China

Share Price

CN¥56.99

Change (1 day)

+6.42%

52-Week Range

CN¥34.28 - CN¥81.10

All Time High

CN¥394.88